SAEDNEWS: A recent study conducted in the UK suggests that a history of endometriosis or uterine fibroids may increase the risk of dying from gynecological cancers before the age of 70.
According to the Family Magazine service of Saed News, the UK’s National Health Service estimates that two out of every three women will experience fibroids—noncancerous growths in or around the uterus—at some point in their lives.
Endometriosis affects roughly 10% of women of reproductive age. It occurs when tissue similar to the uterine lining grows outside the uterus. Diagnosis of endometriosis in women is often delayed for many years.
In this study, researchers analyzed data from over 110,000 women aged 25 to 42, previously collected over three decades—from 1989 to 2019—as part of a long-term investigation into chronic diseases in women.
“We don’t just claim it; we prove that we provide the best care!”
After adjusting for factors such as age, weight, physical activity, and smoking, the study found that endometriosis was associated with a 31% higher risk of premature death, primarily among women who had experienced gynecological cancers.
Although fibroids were generally not linked to early mortality, the analysis indicated that they were associated with an increased risk of death from female-specific cancers.
According to Euronews, the study’s authors concluded that women with a history of endometriosis and uterine fibroids may face a higher risk of early mortality—beyond the span of their reproductive years.
The researchers also found evidence suggesting that both endometriosis and fibroids are linked to chronic conditions such as high blood pressure, heart disease, and certain types of cancer.
Francisco Carmona, a specialist in women’s endometriosis, commented on the study, saying: “This is a robust and well-supported study that underscores the need to consider women’s diseases within the broader context of overall female health. It also highlights the importance of early, individualized management of these conditions.”
He added that future research should independently examine the impact of diagnoses and surgeries involving ovarian removal.
